Carlie Sigel

2.9k total citations · 1 hit paper
67 papers, 1.7k citations indexed

About

Carlie Sigel is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Carlie Sigel has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 32 papers in Surgery and 23 papers in Epidemiology. Recurrent topics in Carlie Sigel's work include Pancreatic and Hepatic Oncology Research (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Neuroendocrine Tumor Research Advances (16 papers). Carlie Sigel is often cited by papers focused on Pancreatic and Hepatic Oncology Research (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Neuroendocrine Tumor Research Advances (16 papers). Carlie Sigel collaborates with scholars based in United States, Germany and United Kingdom. Carlie Sigel's co-authors include David S. Klimstra, Olca Baştürk, Natasha Rekhtman, André L. Moreira, Volkan Adsay, William D. Travis, Maureen F. Zakowski, Gregory J. Riely, Laura H. Tang and Serdar Balcı and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Carlie Sigel

62 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms

2015 341 citations Olca Baştürk, Laura H. Tang et al. profile →

Peers

Carlie Sigel

ONCOL

EPIDE

PRM

SURGE

NEURO

Moritz Jesinghaus Germany

Antonio Pea Italy

Einar Gudlaugsson Norway

Hiroshi Imaoka Japan

Sadanori Takeo Japan

Min‐Shu Hsieh Taiwan

Silvana C. Faria United States

Giovanni Fellegara Italy

Fuquan Zhang China

Nancy P. Caraway United States

Moritz Jesinghaus Germany

Carlie Sigel

1.1k ×1.1

ONCOL

526 ×0.8

EPIDE

409 ×0.9

PRM

492 ×1.1

SURGE

275 ×1.0

NEURO

Citations per year, relative to Carlie Sigel Carlie Sigel (= 1×) peers Moritz Jesinghaus

Countries citing papers authored by Carlie Sigel

Since Specialization

Citations

This map shows the geographic impact of Carlie Sigel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlie Sigel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlie Sigel more than expected).

Fields of papers citing papers by Carlie Sigel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlie Sigel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlie Sigel. The network helps show where Carlie Sigel may publish in the future.

Co-authorship network of co-authors of Carlie Sigel

This figure shows the co-authorship network connecting the top 25 collaborators of Carlie Sigel. A scholar is included among the top collaborators of Carlie Sigel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlie Sigel. Carlie Sigel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petre, Elena N., Erica S. Alexander, Vlasios S. Sotirchos, et al.. (2025). Hepatocellular Carcinoma Growth Kinetics and Outcomes After Transarterial Embolization: A Single-Center Analysis. Cancers. 17(20). 3346–3346.

Zheng, Junting, Tae‐Hyung Kim, James J. Harding, et al.. (2025). CT and MRI features of Catenin Beta 1-mutated hepatocellular carcinoma in a Western cohort. Abdominal Radiology. 51(1). 50–62. 1 indexed citations

Sigel, Carlie, Subrata Chatterjee, Pulkit Jain, et al.. (2024). Extraction and classification of structured data from unstructured hepatobiliary pathology reports using large language models: a feasibility study compared with rules-based natural language processing. Journal of Clinical Pathology. 78(2). 135–138. 4 indexed citations

Soares, Kevin C., Joshua S. Jolissaint, Kenneth Seier, et al.. (2023). Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival. Cancer Medicine. 12(11). 12272–12284. 4 indexed citations

Reyngold, Marsha, Sana D. Karam, Carla Hajj, et al.. (2023). Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(1). 53–63. 5 indexed citations

Sigel, Keith, et al.. (2023). The World Health Organization classification of pancreaticobiliary cytopathology stratifies risk of malignancy and outcome for endoscopic ultrasound‐guided fine‐needle aspiration of the pancreas. Cancer Cytopathology. 131(12). 762–771. 2 indexed citations

Mehta, Paras, Devika Rao, Veronica Rotemberg, et al.. (2022). Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes. Cancer Medicine. 12(1). 179–188. 5 indexed citations

Vakiani, Efsevia, Mithat Gönen, Nancy E. Kemeny, et al.. (2022). Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases. Cancers. 14(3). 693–693. 21 indexed citations

Chakraborty, Saptarshi, Brett L. Ecker, Kenneth Seier, et al.. (2021). Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care. Clinical Cancer Research. 27(21). 5891–5899. 12 indexed citations

10.

Jolissaint, Joshua S., Kevin C. Soares, Kenneth Seier, et al.. (2021). Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clinical Cancer Research. 27(14). 4101–4108. 30 indexed citations

11.

Hassan, Muhammad, Carlie Sigel, Michael Doukas, et al.. (2021). EPIC-Survival: End-to-end Part Inferred Clustering for Survival Analysis, with Prognostic Stratification Boosting. 520–531. 3 indexed citations

12.

Attiyeh, Marc A., Lance Zhang, Christine A. Iacobuzio–Donahue, et al.. (2020). Simple mucinous cysts of the pancreas have heterogeneous somatic mutations. Human Pathology. 101. 1–9. 11 indexed citations

13.

Fulmer, Clifton G., Kyung Park, Susan Alperstein, et al.. (2020). Next‐generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study. Cancer Cytopathology. 128(11). 840–851. 10 indexed citations

14.

Wang, Tao, Esther Drill, Efsevia Vakiani, et al.. (2019). Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma. Human Pathology. 91. 19–25. 12 indexed citations

15.

Liu, Yuxin, Michael Gaisa, Xiaofei Wang, et al.. (2017). Differences in the Immune Microenvironment of Anal Cancer Precursors by HIV Status and Association With Ablation Outcomes. The Journal of Infectious Diseases. 217(5). 703–709. 12 indexed citations

16.

Horvat, Natally, Edmund Godfrey, Jaclyn F. Hechtman, et al.. (2017). Subclinical focal cholangitis mimicking liver metastasis in asymptomatic patients with history of pancreatic ductal adenocarcinoma and biliary tree intervention. Cancer Imaging. 17(1). 21–21. 3 indexed citations

17.

Sigel, Carlie, Diane Reidy‐Lagunes, Oscar Lin, et al.. (2016). Cytological features contributing to the misclassification of pancreatic neuroendocrine tumors. Journal of the American Society of Cytopathology. 5(5). 266–276. 7 indexed citations

18.

Rekhtman, Natasha, Suzanne M. Brandt, Carlie Sigel, et al.. (2011). Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing. Journal of Thoracic Oncology. 6(3). 451–458. 183 indexed citations

19.

Sigel, Carlie, Camelia S. Sima, Natasha Rekhtman, et al.. (2011). Predicting pulmonary adenocarcinoma outcome based on a cytology grading system. Cancer Cytopathology. 120(1). 35–43. 28 indexed citations

20.

Su, Jui‐Lan, Deborah A. Winegar, G. Bruce Wisely, Carlie Sigel, & Emily A. Hull-Ryde. (1999). Use of a PPAR Gamma-Specific Monoclonal Antibody to Demonstrate Thiazolidinediones Induce PPAR Gamma Receptor Expression In Vitro. Hybridoma. 18(3). 273–280. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact